| pubmed-article:16765529 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16765529 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:16765529 | lifeskim:mentions | umls-concept:C0034380 | lld:lifeskim |
| pubmed-article:16765529 | lifeskim:mentions | umls-concept:C0596790 | lld:lifeskim |
| pubmed-article:16765529 | lifeskim:mentions | umls-concept:C0006098 | lld:lifeskim |
| pubmed-article:16765529 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:16765529 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
| pubmed-article:16765529 | lifeskim:mentions | umls-concept:C0392752 | lld:lifeskim |
| pubmed-article:16765529 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:16765529 | pubmed:dateCreated | 2006-8-14 | lld:pubmed |
| pubmed-article:16765529 | pubmed:abstractText | Permanent interstitial brachytherapy (IB) has become an increasingly appealing therapeutic option for localized prostate cancer (LPC) among physicians and patients because it involves short hospitalization and treatment and its postulated low degree of toxicity may reduce its impact on the patients' quality of life (QoL). The aim of this prospective study was to assess the impact of IB on the QoL of patients with LPC. | lld:pubmed |
| pubmed-article:16765529 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16765529 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16765529 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16765529 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16765529 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:16765529 | pubmed:issn | 0360-3016 | lld:pubmed |
| pubmed-article:16765529 | pubmed:author | pubmed-author:CaffoOrazioO | lld:pubmed |
| pubmed-article:16765529 | pubmed:author | pubmed-author:GalligioniEnz... | lld:pubmed |
| pubmed-article:16765529 | pubmed:author | pubmed-author:TomioLuigiL | lld:pubmed |
| pubmed-article:16765529 | pubmed:author | pubmed-author:MalossiniGian... | lld:pubmed |
| pubmed-article:16765529 | pubmed:author | pubmed-author:BolnerAndreaA | lld:pubmed |
| pubmed-article:16765529 | pubmed:author | pubmed-author:MussariSalvat... | lld:pubmed |
| pubmed-article:16765529 | pubmed:author | pubmed-author:FellinGianniG | lld:pubmed |
| pubmed-article:16765529 | pubmed:author | pubmed-author:FrisinghelliM... | lld:pubmed |
| pubmed-article:16765529 | pubmed:author | pubmed-author:CoccarelliFra... | lld:pubmed |
| pubmed-article:16765529 | pubmed:author | pubmed-author:DivanClaudioC | lld:pubmed |
| pubmed-article:16765529 | pubmed:author | pubmed-author:ZiglioFrancoF | lld:pubmed |
| pubmed-article:16765529 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16765529 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:16765529 | pubmed:volume | 66 | lld:pubmed |
| pubmed-article:16765529 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16765529 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16765529 | pubmed:pagination | 31-7 | lld:pubmed |
| pubmed-article:16765529 | pubmed:meshHeading | pubmed-meshheading:16765529... | lld:pubmed |
| pubmed-article:16765529 | pubmed:meshHeading | pubmed-meshheading:16765529... | lld:pubmed |
| pubmed-article:16765529 | pubmed:meshHeading | pubmed-meshheading:16765529... | lld:pubmed |
| pubmed-article:16765529 | pubmed:meshHeading | pubmed-meshheading:16765529... | lld:pubmed |
| pubmed-article:16765529 | pubmed:meshHeading | pubmed-meshheading:16765529... | lld:pubmed |
| pubmed-article:16765529 | pubmed:meshHeading | pubmed-meshheading:16765529... | lld:pubmed |
| pubmed-article:16765529 | pubmed:meshHeading | pubmed-meshheading:16765529... | lld:pubmed |
| pubmed-article:16765529 | pubmed:meshHeading | pubmed-meshheading:16765529... | lld:pubmed |
| pubmed-article:16765529 | pubmed:meshHeading | pubmed-meshheading:16765529... | lld:pubmed |
| pubmed-article:16765529 | pubmed:meshHeading | pubmed-meshheading:16765529... | lld:pubmed |
| pubmed-article:16765529 | pubmed:meshHeading | pubmed-meshheading:16765529... | lld:pubmed |
| pubmed-article:16765529 | pubmed:meshHeading | pubmed-meshheading:16765529... | lld:pubmed |
| pubmed-article:16765529 | pubmed:meshHeading | pubmed-meshheading:16765529... | lld:pubmed |
| pubmed-article:16765529 | pubmed:meshHeading | pubmed-meshheading:16765529... | lld:pubmed |
| pubmed-article:16765529 | pubmed:meshHeading | pubmed-meshheading:16765529... | lld:pubmed |
| pubmed-article:16765529 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16765529 | pubmed:articleTitle | Prospective evaluation of quality of life after interstitial brachytherapy for localized prostate cancer. | lld:pubmed |
| pubmed-article:16765529 | pubmed:affiliation | Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy. orazio.caffo@apss.tn.it | lld:pubmed |
| pubmed-article:16765529 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16765529 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
